Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
Top Cited Papers
- 8 March 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 379 (9826), 1613-1620
- https://doi.org/10.1016/s0140-6736(11)61930-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin ResistanceThe Journal of Pediatrics, 2010
- Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2007–2008 Nationwide SurveyJournal of Epidemiology, 2010
- Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki diseaseEuropean Journal of Pediatrics, 2008
- Analysis of Potential Risk Factors Associated With Nonresponse to Initial Intravenous Immunoglobulin Treatment Among Kawasaki Disease Patients in JapanThe Pediatric Infectious Disease Journal, 2008
- Revisiting steroids in the primary treatment of acute Kawasaki diseaseThe Journal of Pediatrics, 2006
- A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcomeThe Journal of Pediatrics, 2006
- Effect of Initial Corticosteroid Therapy on Coronary Artery Aneurysm Formation in Kawasaki Disease: A Meta-analysis of 862 ChildrenPediatrics, 2005
- CD8 T Lymphocytes and Macrophages Infiltrate Coronary Artery Aneurysms in Acute Kawasaki DiseaseThe Journal of Infectious Diseases, 2001
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease.Japanese Circulation Journal, 1982